logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11485708 B1

PDFFull Text
Date of Patent:
Nov. 01, 2022

Filed:

Jun. 19, 2020

Compounds for treatment of pd-l1 diseases

Applicant:

Chemocentryx, Inc., Mountain View, CA (US);

Inventors:

Viengkham Malathong, Mountain View, CA (US);

Pingchen Fan, Fremont, CA (US);

Christopher Lange, El Cerrito, CA (US);

Venkat Reddy Mali, Cupertino, CA (US);

Darren J. McMurtrie, Sunnyvale, CA (US);

Sreenivas Punna, Sunnyvale, CA (US);

Howard S. Roth, Sunnyvale, CA (US);

Rajinder Singh, Belmont, CA (US);

Ju Yang, Palo Alto, CA (US);

Penglie Zhang, Foster City, CA (US);

Assignee:

ChemoCentryx, Inc., San Carlos, CA (US);

Attorney:

Mintz Levin Cohn Ferris Glovsky and Popeo PC

Primary Examiner:

Golam M Shameem

Int. Cl.
CPC ...
C07D 217/04 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01); A61K 31/4725 (2006.01); C07C 217/58 (2006.01); A61K 31/137 (2006.01); C07D 211/58 (2006.01); A61K 31/4468 (2006.01); A61K 31/4545 (2006.01); C07C 229/16 (2006.01); A61K 31/197 (2006.01); C07D 207/06 (2006.01); A61K 31/40 (2006.01); C07D 319/18 (2006.01); A61K 31/357 (2006.01); C07D 213/64 (2006.01); A61K 31/4402 (2006.01); C07D 215/227 (2006.01); A61K 31/4704 (2006.01); C07C 309/14 (2006.01); A61K 31/185 (2006.01); A61K 31/472 (2006.01);
U.S. Cl.
CPC ...
C07D 217/04 (2013.01); A61K 31/137 (2013.01); A61K 31/185 (2013.01); A61K 31/197 (2013.01); A61K 31/357 (2013.01); A61K 31/40 (2013.01); A61K 31/4402 (2013.01); A61K 31/4468 (2013.01); A61K 31/4545 (2013.01); A61K 31/472 (2013.01); A61K 31/4704 (2013.01); A61K 31/4725 (2013.01); A61K 45/06 (2013.01); C07C 217/58 (2013.01); C07C 229/16 (2013.01); C07C 309/14 (2013.01); C07D 207/06 (2013.01); C07D 211/58 (2013.01); C07D 213/64 (2013.01); C07D 215/227 (2013.01); C07D 319/18 (2013.01); C07D 401/12 (2013.01);
Abstract

Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R, R, R, R, R, R, R, R, R, R, R, R, Rand the subscript n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Find Patent Forward Citations

Loading…